Biography
Jeeyoon Chung is an associate in Weil’s Technology & IP Transactions practice and is based in New York. Jeeyoon participates in advising Firm clients in a variety of matters relating to the licensing, acquisition, development, sale, use and commercial exploitation of intellectual property and technology. She also participates in advising clients regarding privacy and data security issues in the context of corporate transactions.
Jeeyoon has been part of teams advising on the technology and intellectual property aspects, as well as on the data privacy and cybersecurity aspects of the following matters:
- American Securities LLC in the $1.85 billion sale of its portfolio company ASP Acuren Holdings Inc. to Admiral Acquisition Limited
- Charlesbank Capital Partners and its portfolio company Bridges Consumer Healthcare in Bridges’ acquisition of KT Health, LLC
- CIIG Capital Partners II, Inc., a SPAC sponsored by CIIG Management II LLC, in its business combination with Zapp Electric Vehicles Ltd. that implied a combined enterprise value of $573 million
- Goldman Sachs in its acquisition of NextCapital Group, Inc.
- Private Equity at Goldman Sachs Alternatives and its portfolio company Omega Healthcare Management Services in an investment by Ontario Teachers’ Pension Plan, through which Ontario Teachers’ will join Private Equity at Goldman Sachs Alternatives as co-lead investor in Omega Healthcare
- Halozyme Therapeutics, Inc. in its $960 million acquisition of Antares Pharma, Inc.
- The Home Depot in its $18.25 billion acquisition of SRS Distribution Inc.
- ITE Management, L.P. in its strategic minority investment from funds managed by Blackstone Credit & Insurance
- The Kroger Company in its proposed $24.6 billion merger with Albertsons Companies, Inc.
- The Kroger Company, along with The Albertsons Companies, Inc., in the approximately $1.9 billion sale of 413 stores, as well as select banners, distribution centers, offices and private label brands, to C&S Wholesale Grocers, LLC in connection with Kroger’s proposed merger with Albertsons Companies Inc.
- Sanofi in its $9.5 billion acquisition of Blueprint Medicines
- Warburg Pincus, as a co-investor with One Equity Partners, in the formation of Eco Material Technologies Inc. through a business combination with Green Cement Inc. and the $1 billion acquisition of Boral Resources LLC
Jeeyoon joined Weil as a summer associate in 2020.
Jeeyoon received her J.D. from Columbia Law School, where she was a Harlan Fiske Stone Scholar, was the president of the Asian Pacific American Law Students Association and served as the Development and Diversity Editor of the Columbia Law Review, and her B.A. from Johns Hopkins University. At Columbia, she was awarded the Carol B. Liebman Mediation Prize. She is fluent in Korean and French.